Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Watson

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
JAMA|April 21, 2011
Use of whole-genome sequencing to diagnose a cryptic fusion oncogeneJohn S Welch, Peter Westervelt, Li Ding, et al.
The Journal of Chemical Physics|August 2, 2024
Quantum chemical package Jaguar: A survey of recent developments and unique featuresYixiang Cao, Ty Balduf, Michael D Beachy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2020
Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)Raphael Bueno, William G Richards, David H Harpole, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung CarcinomaHui Yu, Zhengming Chen, Karla V Ballman, et al.
JAMA Oncology|January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical TrialCynthia X Ma, Vera J Suman, Souzan Sanati, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Nature Communications|January 29, 2020
Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Eric J Jaehnig, Karsten Krug, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
JAMA|April 21, 2011
Use of whole-genome sequencing to diagnose a cryptic fusion oncogeneJohn S Welch, Peter Westervelt, Li Ding, et al.
The Journal of Chemical Physics|August 2, 2024
Quantum chemical package Jaguar: A survey of recent developments and unique featuresYixiang Cao, Ty Balduf, Michael D Beachy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2020
Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)Raphael Bueno, William G Richards, David H Harpole, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung CarcinomaHui Yu, Zhengming Chen, Karla V Ballman, et al.
JAMA Oncology|January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical TrialCynthia X Ma, Vera J Suman, Souzan Sanati, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Nature Communications|January 29, 2020
Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Eric J Jaehnig, Karsten Krug, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Pageof 13